Fact CheckerSign in

NCT04150718Completed

Role of Slow-wave Activity and Plasticity in MDD

Investigating the Role of Slow-wave Activity as a Marker of Impaired Plasticity in Major Depressive Disorder

Source: ClinicalTrials.gov · Last updated 27 Dec 2024

Brief summary (registry, in English)

The hypothesis underlying this proposal is that deficits of synaptic plasticity underlie the slow-wave activity (SWA) abnormalities observed n major depressive disorder (MDD), and that manipulating SWA may serve to circumvent these deficits by facilitating an increase in synaptic strength via the inhibition of synaptic down-scaling, thereby improving plasticity and mood.

Status (registry)
Completed
Study type
Interventional
Enrollment
77 (actual)
First submitted
7 Oct 2019
Start date
4 Mar 2020
Primary completion date
31 Mar 2023
Lead sponsor
University of Pennsylvania
Diseases
Depression
NCT number
NCT04150718

What you commit to

  • Study type: Interventional
  • Participants enrolled: 77
  • From 4 Mar 2020 to the primary completion date, 31 Mar 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current or prior medical condition
  • travel beyond 2 time zones in the 2 months before study

Other illness

  • History of stroke, epilepsy, brain aneurysm clip or head injury causing unconsciousness
  • Implanted devices (i.e. aneurysm clip or cardiac pacemaker)
  • Sleep disorders other than insomnia
  • History of bipolar disorder, delirium, dementia, amnestic disorder, schizophrenia and other psychotic disorders
  • No history of depression for the control group.
  • Lifetime history of electroconvulsive therapy

Other

  • For women, pregnancy will exclude participation.
  • Unwillingness to refrain from using alcohol or caffeine during the study

Who the study is looking for

  • Age: 25-50
  • Right handed
  • English speaking
  • Normal cognition
  • Normal or corrected-to-normal vision and hearing
  • Current depression as assessed on the SCID and Hamilton Rating Scale for Depression
  • Stable, normally-time sleep-wake cycles as determined by interview, 1-week daily sleep log and 1-week wrist actigraphy evidence

Age in the registry: 25 years to 50 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Pennsylvania, Department of Psychiatry
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.